SC
BSX icon

Savant Capital’s Boston Scientific BSX Stock Holding History

Savant Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.05M Buy
124,870
+100,138
+405% +$5.44M 0.02% 372
2026
Q1 		$1.55M Buy
24,732
+11,776
+91% +$942K 0.01% 485
2025
Q4 		$1.24M Buy
12,956
+10
+0.1% +$980 0.01% 522
2025
Q3 		$1.26M Buy
12,946
+393
+3% +$40.7K 0.01% 496
2025
Q2 		$1.35M Buy
12,553
+963
+8% +$97.4K 0.01% 440
2025
Q1 		$1.17M Sell
11,590
-7,870
-40% -$792K 0.01% 434
2024
Q4 		$1.74M Buy
19,460
+1,294
+7% +$114K 0.01% 475
2024
Q3 		$1.52M Buy
18,166
+3,992
+28% +$315K 0.01% 507
2024
Q2 		$1.09M Buy
14,174
+273
+2% +$20K 0.01% 559
2024
Q1 		$952K Buy
13,901
+946
+7% +$60.8K 0.01% 553
2023
Q4 		$749K Buy
12,955
+350
+3% +$18.7K 0.01% 474
2023
Q3 		$666K Buy
12,605
+4,897
+64% +$257K 0.01% 473
2023
Q2 		$417K Buy
7,708
+1,544
+25% +$80.6K 0.01% 552
2023
Q1 		$308K Buy
+6,164
New +$291K 0.01% 590

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Savant Capital's BSX Position: Q2 2026 in Review

Savant Capital increased its Boston Scientific (BSX) stake by 405% in Q2 2026, buying an estimated $5.44M and bringing the position to 124,870 shares worth $6.05M. The position accounts for 0.02% of the portfolio, ranked #372.

Savant Capital first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Savant Capital held 124,870 shares of Boston Scientific worth $6.05M as of Q2 2026.
  • Savant Capital bought 100,138 Boston Scientific shares in Q2 2026, an estimated $5.44M.
  • Boston Scientific made up 0.02% of Savant Capital's portfolio in Q2 2026, its #372 holding.
  • Savant Capital first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Savant Capital's 13F filing for Q2 2026, filed 10 Aug 2026.